Severe Vulvovaginal Candidiasis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Use in Postmenopausal Women
While candidiasis is reported to occur with SGLT2i, severe genital mycotic infections are not yet a well-recognized adverse effect and may be missed. The presentation in these cases was persistent and severe. Clinicians should have a high index of suspicion in postmenopausal women presenting with vulvar pain, pruritus, and extensive erythema that mimics psoriasis or irritant dermatitis, if they are on SGLT2i therapy.
Authors
- Marlene Wijaya (ORCID: https://orcid.org/0000-0002-3137-5847)
- Gayle Fischer (ORCID: https://orcid.org/0000-0002-6382-2576)
- Vera Y. Miao (ORCID: https://orcid.org/0009-0006-8657-6351)
- Rebecca B. Saunderson (ORCID: https://orcid.org/0000-0001-9670-0041)
Institutions
- The University of Sydney (AU)
- Royal North Shore Hospital (AU)
- Northern Sydney Local Health District (AU)
Publication Details
- Journal
- Journal of Lower Genital Tract Disease
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1097/lgt.0000000000000839
- Citations
- 3
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.27